Swedbank’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $162M | Buy |
6,729,967
+579,102
| +9% | +$15.1M | 0.14% | 121 |
|
|
2026
Q1 | $173M | Buy |
6,150,865
+660,593
| +12% | +$17.6M | 0.18% | 105 |
|
|
2025
Q4 | $137M | Buy |
5,490,272
+627,384
| +13% | +$15.8M | 0.13% | 120 |
|
|
2025
Q3 | $124M | Buy |
4,862,888
+276,059
| +6% | +$6.81M | 0.13% | 131 |
|
|
2025
Q2 | $111M | Buy |
4,586,829
+164,428
| +4% | +$3.83M | 0.13% | 136 |
|
|
2025
Q1 | $112M | Sell |
4,422,401
-708,773
| -14% | -$18.5M | 0.15% | 124 |
|
|
2024
Q4 | $136M | Sell |
5,131,174
-614,657
| -11% | -$16.7M | 0.17% | 108 |
|
|
2024
Q3 | $166M | Buy |
5,745,831
+37,636
| +0.7% | +$1.1M | 0.21% | 94 |
|
|
2024
Q2 | $160M | Buy |
+5,708,195
| New | +$157M | 0.21% | 92 |
|
|
2024
Q1 | – | Sell |
-6,127,611
| Closed | -$176M | – | 680 |
|
|
2023
Q4 | $176M | Buy |
6,127,611
+166,366
| +3% | +$5.03M | 0.28% | 74 |
|
|
2023
Q3 | $198M | Buy |
5,961,245
+388,575
| +7% | +$13.7M | 0.34% | 58 |
|
|
2023
Q2 | $204M | Sell |
5,572,670
-276,691
| -5% | -$10.8M | 0.35% | 58 |
|
|
2023
Q1 | $239M | Sell |
5,849,361
-326,767
| -5% | -$14.1M | 0.47% | 46 |
|
|
2022
Q4 | $316M | Sell |
6,176,128
-540,402
| -8% | -$25.9M | 0.7% | 32 |
|
|
2022
Q3 | $294M | Sell |
6,716,530
-289,168
| -4% | -$14.1M | 0.7% | 31 |
|
|
2022
Q2 | $367M | Buy |
7,005,698
+221,321
| +3% | +$11.3M | 0.83% | 28 |
|
|
2022
Q1 | $351M | Buy |
6,784,377
+1,554,797
| +30% | +$80.7M | 0.65% | 31 |
|
|
2021
Q4 | $305M | Sell |
5,229,580
-3,108
| -0.1% | -$154K | 0.51% | 40 |
|
|
2021
Q3 | $225M | Sell |
5,232,688
-4,029
| -0.1% | -$178K | 0.42% | 46 |
|
|
2021
Q2 | $205M | Buy |
5,236,717
+609,282
| +13% | +$23.7M | 0.38% | 52 |
|
|
2021
Q1 | $168M | Buy |
4,627,435
+301,521
| +7% | +$10.7M | 0.35% | 62 |
|
|
2020
Q4 | $159M | Buy |
4,325,914
+362,361
| +9% | +$13.3M | 0.47% | 60 |
|
|
2020
Q3 | $138M | Buy |
3,963,553
+130,402
| +3% | +$4.57M | 0.47% | 60 |
|
|
2020
Q2 | $119M | Buy |
3,833,151
+367,417
| +11% | +$12.5M | 0.43% | 71 |
|
|
2020
Q1 | $107M | Sell |
3,465,734
-150,428
| -4% | -$5.13M | 0.53% | 58 |
|
|
2019
Q4 | $133M | Sell |
3,616,162
-1,012,748
| -22% | -$36.1M | 0.54% | 66 |
|
|
2019
Q3 | $158M | Buy |
4,628,910
+1,580,416
| +52% | +$57.5M | 0.72% | 48 |
|
|
2019
Q2 | $125M | Buy |
3,048,494
+12,319
| +0.4% | +$489K | 0.57% | 68 |
|
|
2019
Q1 | $122M | Sell |
3,036,175
-499,734
| -14% | -$20M | 0.58% | 60 |
|
|
2018
Q4 | $144M | Sell |
3,535,909
-104,331
| -3% | -$4.33M | 0.79% | 48 |
|
|
2018
Q3 | $152M | Sell |
3,640,240
-79,864
| -2% | -$3.07M | 0.68% | 53 |
|
|
2018
Q2 | $128M | Sell |
3,720,104
-235,114
| -6% | -$8.03M | 0.63% | 52 |
|
|
2018
Q1 | $133M | Buy |
3,955,218
+46,195
| +1% | +$1.59M | 0.69% | 49 |
|
|
2017
Q4 | $134M | Sell |
3,909,023
-15,582
| -0.4% | -$531K | 0.73% | 48 |
|
|
2017
Q3 | $133M | Sell |
3,924,605
-32,402
| -0.8% | -$1.04M | 0.81% | 43 |
|
|
2017
Q2 | $126M | Buy |
3,957,007
+81,885
| +2% | +$2.58M | 0.84% | 46 |
|
|
2017
Q1 | $126M | Sell |
3,875,122
-117,652
| -3% | -$3.71M | 0.89% | 41 |
|
|
2016
Q4 | $123M | Sell |
3,992,774
-416,312
| -9% | -$12.7M | 0.97% | 40 |
|
|
2016
Q3 | $142M | Sell |
4,409,086
-46,703
| -1% | -$1.56M | 1.16% | 33 |
|
|
2016
Q2 | $149M | Sell |
4,455,789
-508,910
| -10% | -$16.2M | 1.26% | 31 |
|
|
2016
Q1 | $140M | Buy |
4,964,699
+1,129,221
| +29% | +$32.3M | 1.14% | 33 |
|
|
2015
Q4 | $119M | Buy |
3,835,478
+48,494
| +1% | +$1.53M | 0.94% | 34 |
|
|
2015
Q3 | $113M | Sell |
3,786,984
-185,840
| -5% | -$5.96M | 0.93% | 37 |
|
|
2015
Q2 | $126M | Sell |
3,972,824
-45,031
| -1% | -$1.47M | 0.93% | 38 |
|
|
2015
Q1 | $133M | Buy |
4,017,855
+131,375
| +3% | +$4.18M | 1.03% | 36 |
|
|
2014
Q4 | $115M | Buy |
+3,886,480
| New | +$111M | 0.89% | 44 |
|
|
2014
Q1 | $133M | Buy |
+4,017,855
| New | +$120M | 1.03% | 36 |
|
Other funds holding PFE
AIM
SLAM
CWP
Swedbank's PFE Position: Q2 2026 in Review
Swedbank increased its Pfizer (PFE) stake by 9.4% in Q2 2026, buying an estimated $15.1M and bringing the position to 6,729,967 shares worth $162M. The position accounts for 0.14% of the portfolio, ranked #121.
Swedbank first reported a position in PFE in Q1 2014 and has held it in 47 quarters since. The position peaked at $367M in Q2 2022. 1,179 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Swedbank held 6,729,967 shares of Pfizer worth $162M as of Q2 2026.
- Swedbank bought 579,102 Pfizer shares in Q2 2026, an estimated $15.1M.
- Pfizer made up 0.14% of Swedbank's portfolio in Q2 2026, its #121 holding.
- Swedbank first reported a position in Pfizer in Q1 2014 and has held it in 47 quarters since.
- Swedbank's Pfizer position peaked at $367M in Q2 2022.
- 1,179 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Swedbank's 13F filing for Q2 2026, filed 15 Jul 2026.